The Shanghai Food and Drug Safety Commission issued the “Shanghai Fifteenth Five-Year Plan” to ensure drug safety and promote high-quality development of the pharmaceutical industry, which proposes to further promote reforms in the pharmaceutical sector. Continue to push forward clinical trial review and approval reforms for innovative drugs, and support innovative drug research and development. Deepen the reform of the review and approval process for supplementary applications for chemicals produced at home and abroad, and provide advance services for major chemical drug change declarations in the city. Seek reforms such as a pilot review of generic drugs to speed up the launch of the first generic product. Streamline the process of changing marketed drugs. Deeply carry out pilot applications of continuous pharmaceutical manufacturing technology. Optimize the working mechanisms and procedures for temporary import services for clinically urgently needed drugs.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.